Trace Neuroscience (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $101,000,000
Company Info
- Company Description
- Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
- Market
- Neurodegenerative diseases
- Location
- South San Francisco, California, USA
- Coinvestors
- Third Rock Ventures, Atlas Venture, GV, RA Capital Management